Fig. 9From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinomaROS detection of four liver sections of different groups of control, harmalol post-treated, DEN and DEN+CCl4 by using DCFH-DA, fluorescent probe by flow cytometric analysisBack to article page